| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to a required notice of breast arterial calcification on |
|
|
certain mammography reports. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. Section 86.013, Health and Safety Code, is |
|
|
amended by adding Subsections (a-1) and (a-2) to read as follows: |
|
|
(a-1) In addition to the notice requirements described by |
|
|
Subsection (a), on completion of a patient's mammogram showing |
|
|
breast arterial calcification a mammography facility certified by |
|
|
the United States Food and Drug Administration or by a |
|
|
certification agency approved by the United States Food and Drug |
|
|
Administration shall provide to the patient the following notice: |
|
|
"This notice contains results of your recent mammogram, |
|
|
including information about breast arterial calcification. Your |
|
|
mammogram shows breast arterial calcification, which is a common |
|
|
result. However, breast arterial calcification may be an indicator |
|
|
of an increased risk of cardiovascular disease. |
|
|
"Please discuss this mammogram result showing breast |
|
|
arterial calcifications with your physician to assess your |
|
|
cardiovascular risks and determine whether additional testing is |
|
|
appropriate for you. This information is provided to you to raise |
|
|
your awareness and inform your conversations with your physician. |
|
|
A report of your mammogram results was sent to your physician. |
|
|
Together you can decide whether additional screening options are |
|
|
right for you based on your mammogram results, individual risk |
|
|
factors, or physical examination." |
|
|
(a-2) The executive commissioner by rule may modify the |
|
|
content of the notice described by Subsection (a-1) based on |
|
|
current medical practice and evidence. |
|
|
SECTION 2. This Act takes effect September 1, 2027. |